Literature DB >> 22297052

Preoperative ultrasonography findings predict the need for repeated surgery in papillary thyroid cancer.

Jennifer L Poehls1, Herbert Chen, Rebecca S Sippel.   

Abstract

OBJECTIVE: To determine the impact of neck ultrasonography in predicting papillary thyroid cancer persistence or recurrence.
METHODS: Between March 2005 and March 2009, we identified patients with a preoperative diagnosis of papillary thyroid cancer. Exclusion criteria included no documented preoperative ultrasonography and initial surgery at an outside institution. Patients with positive preoperative ultrasonography were compared with patients who had negative preoperative ultrasonography by assessing rates of neck dissection, complications, disease persistence or recurrence, and the need for repeated surgery.
RESULTS: Of 127 patients initially identified, 16 did not have preoperative ultrasonography and 4 did not have their initial surgery at our institution, leaving 107 patients in our cohort. Twenty-two patients had positive preoperative ultrasonography and 85 patients had negative preoperative ultrasonography. Patients with positive preoperative ultrasonography had a higher rate of repeated surgery than those with negative preoperative ultrasonography (27% vs 4.7%, P = .003). There was no difference in postoperative complication rates. No patients with negative preoperative ultrasonography and an ultrasound report stating specifically "no suspicious lymph nodes" required repeated surgery.
CONCLUSIONS: Negative preoperative ultrasonography with specific lymph node evaluation predicts a low risk of needing early reoperation. Positive preoperative ultrasonography may be a marker for more aggressive disease and the best predictor of the need for additional surgery in the future.

Entities:  

Mesh:

Year:  2012        PMID: 22297052     DOI: 10.4158/EP11221.OR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  7 in total

1.  Back so soon? Is early recurrence of papillary thyroid cancer really just persistent disease?

Authors:  Maria F Bates; Marcos R Lamas; Reese W Randle; Kristin L Long; Susan C Pitt; David F Schneider; Rebecca S Sippel
Journal:  Surgery       Date:  2017-11-08       Impact factor: 3.982

2.  All thyroid ultrasound evaluations are not equal: sonographers specialized in thyroid cancer correctly label clinical N0 disease in well differentiated thyroid cancer.

Authors:  Sarah C Oltmann; David F Schneider; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2014-09-19       Impact factor: 5.344

Review 3.  New developments in the diagnosis and treatment of thyroid cancer.

Authors:  David F Schneider; Herbert Chen
Journal:  CA Cancer J Clin       Date:  2013-06-24       Impact factor: 508.702

4.  Lymph node ratio predicts recurrence in papillary thyroid cancer.

Authors:  David F Schneider; Haggi Mazeh; Herbert Chen; Rebecca S Sippel
Journal:  Oncologist       Date:  2013-01-23

5.  Impact of lymph node ratio on survival in papillary thyroid cancer.

Authors:  David F Schneider; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2012-12-23       Impact factor: 5.344

6.  Preoperative imaging modalities to predict the risk of regional nodal recurrence in well-differentiated thyroid cancers.

Authors:  Mohammed K AlNoury; Saad M Almuhayawi; Khalid B Alghamdi; Khaled I Al-Noury
Journal:  Int Arch Otorhinolaryngol       Date:  2014-12-08

7.  A new computational model for human thyroid cancer enhances the preoperative diagnostic efficacy.

Authors:  Tuo Li; Jianguo Sheng; Weiqin Li; Xin Zhang; Hongyu Yu; Xueyun Chen; Jianquan Zhang; Quancai Cai; Yongquan Shi; Zhimin Liu
Journal:  Oncotarget       Date:  2015-09-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.